These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25093396)

  • 1. Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression.
    Morimoto SS; Wexler BE; Liu J; Hu W; Seirup J; Alexopoulos GS
    Nat Commun; 2014 Aug; 5():4579. PubMed ID: 25093396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive Dysfunction Predicts Treatment Response to Neuroplasticity-Based Computerized Cognitive Remediation (nCCR-GD) in Elderly Patients with Major Depression.
    Morimoto SS; Gunning FM; Wexler BE; Hu W; Ilieva I; Liu J; Nitis J; Alexopoulos GS
    Am J Geriatr Psychiatry; 2016 Oct; 24(10):816-20. PubMed ID: 27591163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cognitive Control Deficits With Neuroplasticity-Based Computerized Cognitive Remediation in Patients With Geriatric Major Depression: A Randomized, Double-Blind, Controlled Trial.
    Morimoto SS; Altizer RA; Gunning FM; Hu W; Liu J; Cote SE; Nitis J; Alexopoulos GS
    Am J Geriatr Psychiatry; 2020 Sep; 28(9):971-980. PubMed ID: 32591170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a neuroimaging treatment selection biomarker for major depressive disorder.
    McGrath CL; Kelley ME; Holtzheimer PE; Dunlop BW; Craighead WE; Franco AR; Craddock RC; Mayberg HS
    JAMA Psychiatry; 2013 Aug; 70(8):821-9. PubMed ID: 23760393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroplasticity-based computerized cognitive remediation for geriatric depression.
    Morimoto SS; Wexler BE; Alexopoulos GS
    Int J Geriatr Psychiatry; 2012 Dec; 27(12):1239-47. PubMed ID: 22451346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.
    Lavretsky H; Alstein LL; Olmstead RE; Ercoli LM; Riparetti-Brown M; Cyr NS; Irwin MR
    Am J Geriatr Psychiatry; 2011 Oct; 19(10):839-50. PubMed ID: 21358389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder.
    Beheydt LL; Schrijvers D; Docx L; Bouckaert F; Hulstijn W; Sabbe B
    J Affect Disord; 2015 Dec; 188():47-52. PubMed ID: 26342888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.
    Alexopoulos GS; Manning K; Kanellopoulos D; McGovern A; Seirup JK; Banerjee S; Gunning F
    Psychol Med; 2015 Oct; 45(14):3111-20. PubMed ID: 26169527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability.
    Alexopoulos GS; Raue PJ; Kiosses DN; Mackin RS; Kanellopoulos D; McCulloch C; Areán PA
    Arch Gen Psychiatry; 2011 Jan; 68(1):33-41. PubMed ID: 21199963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment.
    Morimoto SS; Alexopoulos GS
    Psychiatr Clin North Am; 2013 Dec; 36(4):517-31. PubMed ID: 24229654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of computerized cognitive remediation therapy (CCRT) for deficits in attention and executive functions in depression: A pilot study.
    Klojčnik M; Bakracevic K
    Appl Neuropsychol Adult; 2023; 30(3):306-314. PubMed ID: 34182842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting disrupted rich-club network organization with neuroplasticity-based computerized cognitive remediation in major depressive disorder patients.
    Shu M; Feng S; Liu J
    Psychiatry Res; 2022 Oct; 316():114742. PubMed ID: 35917652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.
    Brown ES; Howard C; Khan DA; Carmody TJ
    Psychosomatics; 2012; 53(1):75-80. PubMed ID: 22221724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.
    Diaconescu AO; Kramer E; Hermann C; Ma Y; Dhawan V; Chaly T; Eidelberg D; McIntosh AR; Smith GS
    Hum Brain Mapp; 2011 Oct; 32(10):1677-91. PubMed ID: 20886575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.
    Wetherell JL; Petkus AJ; White KS; Nguyen H; Kornblith S; Andreescu C; Zisook S; Lenze EJ
    Am J Psychiatry; 2013 Jul; 170(7):782-9. PubMed ID: 23680817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
    Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
    Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacoeconomic evaluation of escitalopram versus citalopram in the treatment of severe depression in the United Kingdom.
    Wade AG; Toumi I; Hemels ME
    Clin Ther; 2005 Apr; 27(4):486-96. PubMed ID: 15922821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
    Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
    Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhedonia among patients with Major Depressive Disorder: A comparison between patients on escitalopram and healthy controls.
    Ng CG; Wong SK; Loh HS; Yee A
    Clin Ter; 2014; 165(6):e384-90. PubMed ID: 25524191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.